Status and phase
Conditions
Treatments
About
The purpose of the study is to monitor the safety of FS VH S/D and evaluate whether FS VH S/D is superior to standard treatment in reducing blood loss in subjects undergoing total hip replacement with cement-free hip prostheses.
Sex
Ages
Volunteers
Inclusion criteria
Each subject to be included into the study must fulfill the following inclusion criteria:
Exclusion criteria
Subjects fulfilling the following exclusion criteria will not be recruited into the study:
Also patients with abnormal coagulation values due to anticoagulants like coumadins or heparin must be excluded.
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal